Literature DB >> 3999543

Progression of renal failure in patients with renal disease of diverse etiology on protein-restricted diet.

L Oldrizzi, C Rugiu, E Valvo, A Lupo, C Loschiavo, L Gammaro, N Tessitore, A Fabris, G Panzetta, G Maschio.   

Abstract

The rate of progression of early renal failure was evaluated in three groups of adult patients with renal disease of diverse etiology on dietary protein and phosphorus restriction (about 0.6 g/kg of protein, 700 mg of phosphorus) and in a control group of 22 patients with the same renal disease, retrospectively studied, on a free diet. Group 1 had 33 patients with chronic glomerulonephritis (CG), initial serum creatinine (Scr) of 1.4 to 4.3 mg/dl (mean, 2.20), followed for 5 to 94 months (mean, 44). Group 2 had 17 patients with polycystic kidney disease (PKD), Scr 1.3 to 4.7 mg/dl (mean, 2.40), followed for 8 to 81 months (mean, 42). Group 3 had 28 patients with primary chronic pyelonephritis (CP), Scr of 1.5 to 4.5 mg/dl (mean, 2.57), followed for 9 to 92 months (mean, 41). The control group had 22 patients (11 with CG, five with PKD, and six with CP), with Scr 1.7 to 4.1 mg/dl, followed for 6 to 72 months (mean, 24). In the regression analysis between reciprocal creatinine and time, the slopes were -0.0017, -0.0025, and -0.00016 dl/mg/month in the three patient groups on a protein-restricted diet, respectively. The difference between both groups 1 and 2 and group 3 was statistically significant (P less than 0.05). The slopes in patients on a free diet were significantly greater than those found in patients on a protein-restricted diet. The actuarial survival probability at 72 months, assuming as "renal death" a Scr of 10 mg/dl, was 45% in patients with CG, 44% in those with PKD, and 67% in those with CP on a protein-restricted diet.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3999543     DOI: 10.1038/ki.1985.46

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  14 in total

Review 1.  Effect of low-protein diet on renal function: are there definite conclusions from adult studies?

Authors:  N Gretz; J J Lasserre; A Hocker; M Strauch
Journal:  Pediatr Nephrol       Date:  1991-07       Impact factor: 3.714

Review 2.  Management of progressive renal failure: the role of dietary manipulations.

Authors:  A M el Nahas
Journal:  Postgrad Med J       Date:  1987-08       Impact factor: 2.401

Review 3.  Dietary treatment of renal insufficiency.

Authors:  J T Brocklebank; S Wolfe
Journal:  Arch Dis Child       Date:  1993-12       Impact factor: 3.791

4.  Predictive factors of progression of chronic renal insufficiency: a multivariate analysis.

Authors:  Cristina M Bouissou Soares; Eduardo A Oliveira; José Silvério S Diniz; Eleonora M Lima; Mônica M Vasconcelos; Gilce R Oliveira
Journal:  Pediatr Nephrol       Date:  2003-03-21       Impact factor: 3.714

5.  Comparison of the steady-state pharmacokinetics of fosinopril, lisinopril and enalapril in patients with chronic renal insufficiency.

Authors:  D A Sica; R E Cutler; R J Parmer; N F Ford
Journal:  Clin Pharmacokinet       Date:  1991-05       Impact factor: 6.447

6.  [Drug treatment of chronic glomerulonephritis: pro].

Authors:  K Kühn; J Brodehl; K M Koch; U Helmchen
Journal:  Klin Wochenschr       Date:  1985-09-16

7.  [Drug treatment of chronic glomerulonephritis: contra].

Authors:  K Andrassy; R Waldherr; E Ritz
Journal:  Klin Wochenschr       Date:  1985-09-16

8.  Renal effects of angiotensin converting enzyme inhibitors: nondiabetic chronic renal disease.

Authors:  J A Opsahl; P A Abraham; W F Keane
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

9.  Controlled low protein diets in chronic renal insufficiency: meta-analysis.

Authors:  D Fouque; M Laville; J P Boissel; R Chifflet; M Labeeuw; P Y Zech
Journal:  BMJ       Date:  1992-01-25

10.  Two different therapeutic regimes in patients with sequelae of hemolytic-uremic syndrome.

Authors:  María Gracia Caletti; Horacio Lejarraga; Diana Kelmansky; Mabel Missoni
Journal:  Pediatr Nephrol       Date:  2004-06-18       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.